© 2020 MJH Life Sciences and Cure Today. All rights reserved.
© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
October 29, 2019
The development of the drug Herceptin (trastuzumab) to treat HER2-positive breast cancer marked an enormous milestone: In the opinion of many, it represented the birth of targeted therapy for cancer.
October 30, 2019
From the Chairman
We hope this issue helps answer your questions about treatments and side effects, leaving you better informed and more confident as you make decisions about your care.
Liquid biopsies may reveal who needs treatment for recurrent breast cancer — and, just as important, who doesn’t.
October 31, 2019
Two decades ago, a patient with HER2-positive breast cancer had a single targeted drug option. Now a plethora of new and emerging treatments fill the landscape.
November 01, 2019
In a gel applied directly to the breasts, the anti-estrogen drug tamoxifen may help prevent cancer and fight DCIS — with few side effects.
New treatments are lengthening life and improving its quality for some with metastatic breast cancer.
November 04, 2019
Drugs in the News
Linking a targeted drug to a chemotherapy shows promise for treating metastatic triple-negative breast cancer.
Most who undergo mastectomy lose feeling in their chests, but microsurgeons can now restore sensation by connecting nerves during tissue-based reconstruction.
November 06, 2019
Survivors at risk of lymphedema are asked to follow a standard list of lifestyle adaptations, but two experts say those guidelines may change.
Want to support someone during cancer treatment? Offer your ear, not your opinion.
November 05, 2019
Before undergoing genetic testing, stop to consider its effect on your daily experience, including your ability to get life insurance.